Martingale Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,701
| Closed | -$225K | – | 798 |
|
|
2025
Q1 | $225K | Sell |
6,701
-15,783
| -70% | -$529K | 0.01% | 727 |
|
|
2024
Q4 | $1.15M | Buy |
22,484
+410
| +2% | +$21K | 0.03% | 444 |
|
|
2024
Q3 | $1.13M | Buy |
+22,074
| New | +$1.13M | 0.03% | 433 |
|
|
2023
Q4 | – | Sell |
-44,377
| Closed | -$1.32M | – | 801 |
|
|
2023
Q3 | $1.32M | Sell |
44,377
-3,803
| -8% | -$113K | 0.03% | 363 |
|
|
2023
Q2 | $868K | Hold |
48,180
| – | – | 0.02% | 482 |
|
|
2023
Q1 | $774K | Buy |
48,180
+2,500
| +5% | +$40.2K | 0.01% | 513 |
|
|
2022
Q4 | $836K | Buy |
+45,680
| New | +$836K | 0.02% | 507 |
|